KYTHERA Biopharmaceuticals Inc (KYTH.OQ)
KYTH.OQ on NASDAQ Stock Exchange Global Select Market
26.78USD
10:54am EDT
26.78USD
10:54am EDT
Price Change (% chg)
$-0.78 (-2.83%)
$-0.78 (-2.83%)
Prev Close
$27.56
$27.56
Open
$27.79
$27.79
Day's High
$27.79
$27.79
Day's Low
$26.64
$26.64
Volume
2,500
2,500
Avg. Vol
22,086
22,086
52-wk High
$31.87
$31.87
52-wk Low
$18.49
$18.49
About
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market. The Company’s initial focus is on the facial aesthetics market. The Company’s product candidate, ATX-101, is a injectable drug in... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $506.68 |
| Shares Outstanding (Mil.): | 18.38 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| KYTH.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -3.02 | -- | -- |
| ROI: | -90.99 | -2.58 | 18.76 |
| ROE: | -- | -2.66 | 19.59 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$368.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

